These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12539080)

  • 1. First things first: balancing hepatitis C and human immunodeficiency virus.
    Graham CS; Koziel MJ
    Clin Infect Dis; 2003 Feb; 36(3):368-9. PubMed ID: 12539080
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.
    Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD;
    Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between HIV-1 and HCV infections: towards a new entity?
    Winnock M; Salmon-Céron D; Dabis F; Chêne G
    J Antimicrob Chemother; 2004 Jun; 53(6):936-46. PubMed ID: 15117928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
    J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of hepatitis C in HIV-coinfection.
    Rockstroh JK; Vogel M
    Eur J Med Res; 2004 Jun; 9(6):304-8. PubMed ID: 15257871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
    Núñez M; Soriano V
    J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study.
    Anderson KB; Guest JL; Rimland D
    Clin Infect Dis; 2004 Nov; 39(10):1507-13. PubMed ID: 15546088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coinfection with HIV and hepatitis C virus and immune restoration during HAART.
    Manfredi R
    Clin Infect Dis; 2006 Jan; 42(2):298-9. PubMed ID: 16355345
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children.
    Micheloud D; Jensen J; Bellón JM; Gurbindo D; de José MI; Moreno D; Ramos JT; Muñoz-Fernández MA; Resino S;
    Pediatr Infect Dis J; 2007 Sep; 26(9):846-9. PubMed ID: 17721385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection].
    Bani-Sadr F
    Gastroenterol Clin Biol; 2003 May; 27(5):528-33. PubMed ID: 12843917
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiretroviral treatment with nucleoside analogs does not decrease the viremia of the hepatitis C virus in patients with HIV-1 infection].
    Macías J; Sánchez-Quijano A; Rey C; Lissen E
    Med Clin (Barc); 1998 Jun; 111(3):118-9. PubMed ID: 9706609
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of viral hepatitis on HIV infection.
    Rockstroh JK
    J Hepatol; 2006; 44(1 Suppl):S25-7. PubMed ID: 16338020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
    Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
    Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
    Voirin N; Trépo C; Miailhes P; Touraine JL; Chidiac C; Peyramond D; Livrozet JM; Ritter J; Chevallier P; Fabry J; Allard R; Vanhems P
    J Viral Hepat; 2004 Nov; 11(6):559-62. PubMed ID: 15500557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing antiretroviral therapy for HCV coinfected people.
    Swan T
    GMHC Treat Issues; 2006; 20(4-7):9-11. PubMed ID: 17228450
    [No Abstract]   [Full Text] [Related]  

  • 20. Mortality in patients coinfected with hepatitis B virus and HIV: could antiretroviral therapy make a difference?
    Jain MK
    Clin Infect Dis; 2009 Jun; 48(12):1772-4. PubMed ID: 19435435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.